Press release
Rising Tobacco Consumption Fuels Growth In The Non-Small Cell Lung Cancer (NSCLC) Market: A Key Driver Powering Non-Small Cell Lung Cancer (NSCLC) Market Growth In 2025
Non-Small Cell Lung Cancer (NSCLC)
What Is the Current Non-Small Cell Lung Cancer (NSCLC) Market Size and Its Estimated Growth Rate?
The market capacity for non-small cell lung cancer (NSCLC) has experienced considerable growth in recent times. The trend is likely to continue, with projections showing an increase from $20.1 billion in 2024 to $22.35 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.1%. The growth trajectory during the historical phase can be linked to the advancements in immunotherapy, genomic profiling, and precision medicine, along with the expansion of clinical trials and initiatives aimed at smoking cessation.
The size of the non-small cell lung cancer (NSCLC) market is anticipated to experience substantial growth in the forthcoming years. It is forecasted to reach $33.29 billion by 2029, with a compound annual growth rate (CAGR) of 10.5%. This expansion during the projected period is attributed to the advent of combination treatment options, the incorporation of artificial intelligence (AI), the growth of personalized vaccines, worldwide cooperative research efforts, and patient-focused care. Key trends projected in this period include the use of telemedicine in oncology, liquid biopsy technologies, improvements in diagnostic technologies, the application of minimally invasive surgery techniques, and immune checkpoint inhibitors.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13232
How Are Emerging Segments Shaping the Non-Small Cell Lung Cancer (NSCLC) Market Landscape?
The non-small cell lung cancer (NSCLC) market covered in this report is segmented -
1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types
2) By Therapy: Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution Channels
Subsegments:
1) By Squamous Cell Carcinoma: Keratinizing Squamous Cell Carcinoma, Non-Keratinizing Squamous Cell Carcinoma
2) By Large Cell Carcinoma: Undifferentiated Large Cell Carcinoma, Large Cell Neuroendocrine Carcinoma
3) By Adenocarcinoma: Invasive Adenocarcinoma, Bronchioloalveolar Carcinoma
4) By Other Types: Mixed Cell Type Carcinoma, Sarcomatoid Carcinoma
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13232&type=smp
Which Growth Factors Are Influencing Non-Small Cell Lung Cancer (NSCLC) Market Expansion?
The growth of the non-small cell lung cancer (NSCLC) market is predicted to be fueled by an escalating trend in tobacco consumption. The term tobacco consumption encompasses the intake of tobacco products in various forms such as smoking, chewing, or snuffing. The process inducts nicotine and several other chemicals into your system. Multiple carcinogens are elements of tobacco smoke, which can wreak havoc on the DNA in lung cells, thereby causing mutations and impulsive growth of cancer cells including NSCLC. Case in point, as per the 2024 National Youth Tobacco Survey released by the US Food and Drug Administration (USFDA), a federal agency in the US, as of October 2024, 1.1% of all students (roughly 2.25 million) were presently using tobacco products. This includes 10.1% of high school students (close to 1.58 million) and 5.4% of middle school students (nearly 640,000). Additionally, 2.8% of students (around 760,000) were using any combustible tobacco product currently, while roughly 840,000 or 3.0% reported the use of many tobacco products. Thus, the rising rate of tobacco consumption is likely to cause the NSCLC market to swell. Non-Small Cell Lung Cancer (NSCLC) Market Driver: Escalating Air Pollution Levels Correlated With Rising Non-Small Cell Lung Cancer (Nsclc) Cases
Who Are the Dominant Players Across Different Non-Small Cell Lung Cancer (NSCLC) Market Segments?
Major companies operating in the non-small cell lung cancer (NSCLC) market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Almirall S.A., Clovis Oncology, Revolution Medicines
What Are the Latest Developing Trends in the Non-Small Cell Lung Cancer (NSCLC) Market?
A significant focus for leading firms in the non-small cell lung cancer (NSCLC) market is developing various treatment strategies, such as monotherapy treatments, to gain an upper hand in the market competition. Monotherapy treatment refers to the use of a solitary drug or therapy for treating a specific medical disorder or condition. It concentrates on using a single method or treatment approach rather than a blend of multiple interventions. For example, in June 2022, Novartis AG, a pharmaceutical company based in Switzerland, was granted approval by the European Commission (EC), the Belgium-based authority, for the use of Tabrecta (capmatinib) in treating adult patients with advanced non-small cell lung cancer with METex14 skipping. This offers a new targeted therapeutic choice for patients in Europe who have previously received treatment and have advanced non-small cell lung cancer (NSCLC) with mutations causing MET exon 14 (METex14) skipping. This is currently the most sought-after targeted treatment for advanced NSCLC associated with METex14 skipping modifications.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report
Which Geographic Regions Are Expected to Dominate the Non-Small Cell Lung Cancer (NSCLC) Market in the Coming Years?
North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (NSCLC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Non-Small Cell Lung Cancer (NSCLC) Market?
2. What is the CAGR expected in the Non-Small Cell Lung Cancer (NSCLC) Market?
3. What Are the Key Innovations Transforming the Non-Small Cell Lung Cancer (NSCLC) Industry?
4. Which Region Is Leading the Non-Small Cell Lung Cancer (NSCLC) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Tobacco Consumption Fuels Growth In The Non-Small Cell Lung Cancer (NSCLC) Market: A Key Driver Powering Non-Small Cell Lung Cancer (NSCLC) Market Growth In 2025 here
News-ID: 4029526 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for NSCLC
NSCLC Treatment Market Size, Drugs, Emerging Therapies and Companies 2032 | Delv …
DelveInsight's "NSCLC Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the NSCLC, historical and forecasted epidemiology as well as the NSCLC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Explore the intricate details of the NSCLC Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive NSCLC Market Forecast. Click here to stay ahead in healthcare…
Huateng Pharma Supplies Intermeidates of Pemetrexed Against NSCLC
Pemetrexed disodium is a drug successfully developed by Eli Lilly in the United States for the treatment of tumors, patent protection to January 2017. Pemetrexed disodium is a multi-targeted anti-folate agent with a core pyrrolopyrimidine moiety in its structure. It is a dual inhibitor of nucleotide synthase/dihydrofolate reductase, which inhibits cell replication by disrupting the normal process of folate-dependent metabolism in cells and simultaneously blocking three different enzyme targets critical…
NSCLC Market Global Industry Analysis and Forecast Till 2027
Any type of epithelial lung cancer that isn't small cell lung cancer is referred to as NSCLC (SCLC). Squamous cell carcinoma, large cell carcinoma, and adenocarcinoma are the most common kinds of NSCLC, although there are several more types that are less common, and all types can occur in atypical histologic variants.
Request Sample Copy of this Report: https://www.infinitybusinessinsights.com/request_sample.php?id=562904
Top Key Players Included in This Report: Merck KGa, Roche, Nlyte, Taxotere,…
Targeted Drugs for NSCLC Market Size by 2025: QY Research
Global Targeted Drugs for NSCLC market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player’s various strategies to sustain in the global market. This report covers five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data. Apart from this, the report also covers detail…
"NSCLC - Market Outlook and Competitive Landscape Report 2015 – 2030 "
Report Snapshot:
NSCLC is the most common form of lung cancer, accounting for approximately 85% of all types and subtypes of lung cancer. It grows and spreads more slowly than small cell lung cancer. Early stage disease is associated with uncommon specific symptoms; hence roughly ~50% to 73% of cases are not being diagnosed until the disease is at an advanced stage when the chances for cure or significant patient benefit…
Global cancer immunotherapies Market 2016:Melanoma, Prostate cancer, NSCLC
Cancer Immunotherapies has brought an unprecedented change in the global cancer therapies market. Cancer immunotherapy can be defined as, the treatment that deploys the bodys immune system, by joining and boosting innate powers of the immune system to fight cancer.
Over the past few years, cancer immunotherapies have generated new waves of optimism in the global oncology market, unveiling huge untapped potential for the innovators. After years of jostling over how…
